Insiders Sensei Biotherapeutics, Inc.

Equities

SNSE

US81728A1088

Delayed Nasdaq Other stock markets 02:38:24 2024-04-29 pm EDT			5-day change	1st Jan Change
1.01 ^USD	-0.98%		+8.50%	+45.95%

Apr. 24	Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting	CI
Apr. 04	Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of Vista Within the Tumor Microenvironment	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sensei Biotherapeutics, Inc. Announces Management Changes	Feb. 08	CI
Sensei Biotherapeutics, Inc. Appoints Stephanie Krebs, Ms, Mba, as Chief Business Officer	Nov. 01	CI
Apeiron Investment Withdraws its Notice of Intent to Nominate Director at Sensei Biotherapeutics	23-05-23	CI
Sensei Biotherapeutics Confirms the Receipt of Nominations from Apeiron Investment Group	23-03-10	CI
Apeiron Investment Nominates Candidates to the Board of Sensei Biotherapeutics	23-03-09	CI
Sensei Biotherapeutics, Inc. Announces Executive Changes	22-12-08	CI
Sensei Biotherapeutics Appoints Patrick Gallagher, MBA, MPH, as Chief Business Officer	22-06-01	CI
Sensei Biotherapeutics, Inc. Appoints William Ringo as Chair of Its Board of Directors and as A Member of Compensation Committee and Nominating and Corporate Governance Committee	22-03-09	CI
Insider Buy: Sensei Biotherapeutics	22-01-27	MT
Insider Buy: Sensei Biotherapeutics	22-01-18	MT
Sensei Biotherapeutics Appoints Erin Colgan as CFO	22-01-06	MT
Sensei Biotherapeutics, Inc. Appoints Erin Colgan as Chief Financial Officer	22-01-06	CI
Sensei Biotherapeutics, Inc. Appoints Robert Pierce as Chief Research & Development Officer	22-01-06	CI
Faron Pharmaceuticals Names New Chief Medical Officer	22-01-04	MT
Finland's Faron Pharmaceuticals Names Chief Medical Officer	22-01-03	MT
Insider Buy: Sensei Biotherapeutics	21-12-30	MT
Sensei Biotherapeutics Named a Winner of Comparably’s Best CEO Award	21-12-16	AQ
Sensei Biotherapeutics, Inc. Appoints Kristian Humer as Director and as Member of the its Audit Committee	21-08-02	CI
Sensei Biotherapeutics, Inc. Announces Termination of Employment of Anupama Hoey, Effective as of June 18, 2021	21-06-17	CI
Sensei Biotherapeutics Inc. Announces Advisory Board Appointments	21-05-05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SENSEI BIOTHERAPEUTICS : Mixed Q3; but cash cushion remains intact

November 10, 2022 at 06:59 am EST